Strados Labs Named a Winner of 2022 Best of Sensors Awards
Recognized in the Wearable Category for the first-of-its-kind smart sensor platform for respiratory health, RESP® Philadelphia, PA, July 14, 2022 – Today, Strados Labs announces it has been named a winner in the Wearables category of the 2022 Best of Sensors Awards...
Strados Labs Receives FDA 510(k) Clearance for Home Use of its Smart Sensor Platform for Respiratory Health, RESP®
Philadelphia, PA May 3, 2022 — Strados Labs, a medical technology company harnessing the power of smart sensors, machine learning and proprietary algorithms to provide early detection and predictions of worsening respiratory diseases, today announced it has received...
Medtech Company, Strados Labs, Awarded National Science Foundation SBIR Phase II Grant
Funding will help Strados advance the power of its smart sensors to provide early detection and predictions of infectious respiratory diseases Philadelphia, PA, March 10, 2020 — Strados Labs, a medical technology company harnessing the power of smart sensors, machine...
Strados Labs, Growing Medtech Company, Raises $4.5M in Pre-series A Funding Round
Funding to fuel next key milestones as company continues to target asthma, COPD and infectious respiratory diseases in 2022 Philadelphia, PA January 5, 2022 — Strados Labs, a medical technology company harnessing the power of smart sensors, machine learning and...
Recent Comments